The store will not work correctly when cookies are disabled.
3-Allyl-11-butyl-3,11-dihydro-1,3,5,10,11-pentaaza-benzo[b]fluoren-4-one
ID: ALA1277231
PubChem CID: 1929538
Max Phase: Preclinical
Molecular Formula: C19H19N5O
Molecular Weight: 333.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCn1cnc2c(c1=O)c1nc3ccccc3nc1n2CCCC
Standard InChI: InChI=1S/C19H19N5O/c1-3-5-11-24-17-15(19(25)23(10-4-2)12-20-17)16-18(24)22-14-9-7-6-8-13(14)21-16/h4,6-9,12H,2-3,5,10-11H2,1H3
Standard InChI Key: JQKWOUWHWOHAQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.3722 -23.7236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3710 -24.5504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0854 -24.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0836 -23.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7986 -23.7199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7994 -24.5463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5142 -24.9569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5085 -23.3060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2240 -23.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2318 -24.5440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0246 -24.7934 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0120 -23.4488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5038 -24.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3235 -24.0252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6578 -23.2669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1660 -22.5991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3399 -22.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2877 -25.5748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8501 -22.0264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4973 -21.8441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3168 -21.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0960 -25.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3593 -26.5189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1675 -26.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6481 -20.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 9 1 0
12 13 2 0
2 3 2 0
5 6 1 0
3 6 1 0
6 7 2 0
7 10 1 0
1 2 1 0
12 17 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
9 8 1 0
11 18 1 0
8 5 2 0
17 19 2 0
9 10 2 0
16 20 1 0
5 4 1 0
20 21 1 0
4 1 2 0
18 22 1 0
22 23 1 0
10 11 1 0
23 24 1 0
11 13 1 0
21 25 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.40 | Molecular Weight (Monoisotopic): 333.1590 | AlogP: 3.28 | #Rotatable Bonds: 5 |
Polar Surface Area: 65.60 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.40 | CX LogP: 3.49 | CX LogD: 3.49 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.53 | Np Likeness Score: -1.29 |
References
1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G.. (2010) Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors., 18 (22): [PMID:20951595] [10.1016/j.bmc.2010.09.065] |